Serious flaws in the horizontal approach to biotechnology risk.
Miller
H I
HI
Office of Biotechnology, U.S. Food and Drug Administration, Rockville, MD 20857.
Gunary
D
D
D001709:Biotechnology / Q000592:standards; D004274:DNA, Recombinant; D011640:Public Policy; D012306:Risk; D012308:Risk Management / Q000379:methods
D004274:DNA, Recombinant